Page last updated: 2024-10-28

ibudilast and Idiopathic Parkinson Disease

ibudilast has been researched along with Idiopathic Parkinson Disease in 1 studies

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwenkgrub, J1
Zaremba, M1
Joniec-Maciejak, I1
Cudna, A1
Mirowska-Guzel, D1
Kurkowska-Jastrzębska, I1

Other Studies

1 other study available for ibudilast and Idiopathic Parkinson Disease

ArticleYear
The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Animals; Astrocytes; Disease Models, Animal; Glial Cell Line-Derived Neurotrophic Factor; Interleuki

2017